Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hyperlane (HYPER) vs Injective (INJ) Price & Performance

HyperlaneTrade
InjectiveTrade

Price performance (Past 24H)

Key statistics

Hyperlane vs Injective — how do they compare? Hyperlane trades at Rp1,302 (market cap Rp441,26M, Rp215,46M 24h volume), while Injective trades at Rp92,062 (market cap Rp9,23T, Rp1,78T 24h volume). The key difference: Injective is far larger — about 20917.4× Hyperlane's market cap, and Hyperlane's supply is capped (338,2M / 1B HYPER (34%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Hyperlane for 30 Days and Injective for 36 Days on average.

HYPERINJ
Market Cap
Rp441,26MRp9,23T
Volume (24h)
Rp215,46MRp1,78T
Circulating Supply
338,2M / 1B HYPER (34%)100M INJ
Typical Hold Time
30 Days36 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hyperlane

Hyperlane is trading at Rp1,294 with a bearish technical outlook, as indicated by moving averages and ADX signals. The current price sits between support at Rp1,203 and resistance at Rp1,284, with neutral RSI readings suggesting limited momentum. No recent protocol updates or ecosystem news are available, indicating a quiet fundamental period for the token.

Overall outlook remains cautious due to bearish technicals and low circulation rate (34%). Key opportunities include potential rebounds from support levels, but major risks involve high volatility, low liquidity (market cap Rp437.17M), and the absence of recent developmental catalysts, requiring careful risk management.

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HYPER
98% Buy2% Sell
Avg holding period · 30 Days
INJ
29% Buy71% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About Hyperlane

Hyperlane is an innovative interoperability layer designed to connect the modular blockchain ecosystem. It facilitates seamless communication across different blockchain environments, including Layer 1s, rollups, and app-chains. Created for permissionless deployment, Hyperlane enables developers to easily bridge chains while providing customizable security models tailored to the specific requirements of their applications.

Read more on HYPER

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ